Sales and Marketing

The FDA has awarded approval to Jazz Pharma and PharmaMar for Zepzelca (lurbinectedin) as a treatment for metastatic small cell …

Marc Princen was revealed in mid-June as the new Global Chief Executive Officer (CEO) of the Mundipharma network, having taken …

Marie Manley, Partner, and Bethany Wise, Trainee Solicitor, at Sidley Austin look at UK and EU life sciences regulatory developments …

Janssen has revealed new data on its interleukin (IL)-23 inhibitor Tremfya (guselkumab) at the American Academy of Dermatology (AAD) virtual …

China reported its highest amount of coronavirus cases in months as a new outbreak has been linked to a food …

Multiple European governments have been involved in a deal with AstraZeneca to access a supply of the British drugmakers’ potential …

Roche’s Rozlytrek (entrectinib) has secured recommendation for NHS use in England and Wales after NICE backed the drug in final …

AbbVie have announced positive results from its latest Phase 3 clinical trial where Venclexta plus azacitidine improved survival and remission …

Takeda continues its mission to reduce its debt in the wake of its $49 billion acquisition of Shire in January …

Mylan and Biocon have scored FDA approval with their insulin glargine injection Semglee, a biosimilar to Sanofi’s Lantus, in both …

The news this week continues to be dominated by breakthroughs in COVID-19 treatments, with a US clinical trial of the …

Digital health covers everything from algorithms identifying new drug combinations, to mobile phone apps to help patient adherence. The past …

Immatics Biotechnologies welcomed former GlaxoSmithKline executive Dr Cedrik Britten to the company as its new Chief Medical Officer (CMO) on …

Vertex has revealed that it has secured a new approval from the European Commission for its therapy Kalydeco (ivacaftor) in …

The European Medicines Agency has received the application from Gilead for the first conditional marketing authorisation (CMA) of its antiviral …